SI-BONE, Inc.
Health
Performance
6.8
Risk
Sell
Buy
Curious about the Scores? Learn more.

SI-BONE, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

16.01.2026
Momentum tanked. Clearly underperforming.
13.01.2026
Breaking down. The red game over screen is flashing.
13.01.2026
Trouble brewing. Volatility and pressure rising.

SI-BONE, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does SI-BONE, Inc. do? Business model and key facts

Get the full picture of SI-BONE, Inc.: what it builds, where it operates, and how it makes money.

SI-BONE, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 349

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

shop
Company facts
Laura A. Francis
CEO
349
Employees worldwide
shop
Performance
6.74%
Last 12 months
-38.27%
Last 5 years
shop
Growth
$167,18M
Revenue year
$-30.913.000
Net income
shop
Valuation
$762,78M
Market Cap
-18.81
Price/Earnings Ratio

Stocks related to SI-BONE, Inc.

Selected based on industry alignment and relative market positioning.

INMD
InMode Ltd.
13.93
-0.89%
6.5
Sell
Buy
InMode Ltd.
IART
Integra LifeSciences Holdings Corporation
12.36
-2.33%
8.4
Sell
Buy
Integra LifeSciences Holdings Corporation
CNMD
CONMED Corporation
41.20
-3.17%
6.6
Sell
Buy
CONMED Corporation
CTKB
Cytek Biosciences, Inc.
5.48
-2.45%
7.7
Sell
Buy
Cytek Biosciences, Inc.
PACB
Pacific Biosciences of California, Inc.
2.27
-3.62%
9.2
Sell
Buy
Pacific Biosciences of California, Inc.

SI-BONE, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.